stage II adult diffuse mixed cell lymphoma
Showing 9976 - 10000 of >10,000
HER2 Negative Breast Cancer Not Immediately Operated Trial (Ribociclib Oral Tablet)
Not yet recruiting
- HER2 Negative Breast Cancer Not Immediately Operated
- Ribociclib Oral Tablet
- (no location specified)
Dec 16, 2022
Plasma Cell Leukemia Trial in Tianjin (anti-BCMA CAR-T)
Recruiting
- Plasma Cell Leukemia
- anti-BCMA CAR-T
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital Chinese Acad
May 13, 2023
Neuropathy;Peripheral Trial in Tanta (Placebo tablets, Ketotifen Oral Tablet)
Not yet recruiting
- Neuropathy;Peripheral
- Placebo tablets
- Ketotifen Oral Tablet
-
Tanta, EgyptTanta university
Nov 23, 2022
Solid Tumor Trial in Shanghai (LB4330)
Recruiting
- Solid Tumor
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 31, 2023
Periprosthetic Knee Infection Trial in Denmark (one-stage, two-stage)
Recruiting
- Periprosthetic Knee Infection
- one-stage
- two-stage
-
Aalborg, Denmark
- +11 more
Aug 26, 2021
PDAC - Pancreatic Ductal Adenocarcinoma Trial in Verona (Register)
Recruiting
- PDAC - Pancreatic Ductal Adenocarcinoma
- Register
-
Verona, ItalyAOUI Verona
May 3, 2023
Healthy Trial in Davis (Cocoa flavanols I, Control I, Cocoa flavanols II)
Completed
- Healthy
- Cocoa flavanols I
- +3 more
-
Davis, CaliforniaRagle Human Nutrition Research Center, Department of Nutrition a
May 18, 2022
Tumor, Solid, Pancreatic Cancer Trial in Chapel Hill (Ulixertinib, Palbociclib)
Recruiting
- Tumor, Solid
- +2 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Nov 30, 2022
Post-Operative Confusion Trial in Massy (Venus Jugular O2 Saturation optical fiber)
Recruiting
- Post-Operative Confusion
- Venus Jugular O2 Saturation optical fiber
-
Massy, Île De France, FranceJacques CARTIER Private Hospital
May 31, 2023
Leukemia, T-cell Prolymphocytic Leukemia (T-PLL), Cancer Trial in Worldwide (Venetoclax, Ibrutinib)
Completed
- Leukemia
- +2 more
-
Boston, Massachusetts
- +14 more
Nov 23, 2022
T-bet B Cells in Persistent Virus Control After Discontinuance
Completed
- Chronic HBV Infection
- Drug Withdrawal
- T-bet B cell
-
Shanghai, ChinaChanghai hospital
Sep 1, 2023
Alzheimer, Dementia, Gamification Trial (The MapHabit system)
Not yet recruiting
- Alzheimer Disease
- +3 more
- The MapHabit system
- (no location specified)
Jun 13, 2022
Peripheral Blood Mononuclear Cells From Healthy Subjects
Not yet recruiting
- Disease of the Blood
- (no location specified)
Sep 26, 2022
Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Virtual group based physical activity (BurnAlong) and Social Media
Recruiting
- Cancer
- +21 more
- Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Dec 7, 2022
Paramedic Independent Prescribing in Emergency and Urgent Care
Enrolling by invitation
- Paramedic Independent Prescribing
-
Southampton, Hampshire, United KingdomThe University of Southampton
Oct 24, 2023
Idiopathic Pulmonary Fibrosis (IPF) Trial (XFB-19, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis (IPF)
- XFB-19
- Placebo
- (no location specified)
Jul 14, 2022
Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)
Not yet recruiting
- Carcinoma, Hepatocellular
- Atezolizumab
- +3 more
- (no location specified)
Jun 15, 2023
Physical and Emotional Coping Variables in Climacteric Women
Recruiting
- Menopausal Women
- observational
-
Valencia, SpainGemma V Espí-López
Aug 15, 2022
Bacterial Infections Trial in Orlando (XNW4107, Imipenem/Cilastatin, )
Active, not recruiting
- Bacterial Infections
- XNW4107
- +2 more
-
Orlando, FloridaOrlando Clinical Research Center (OCRC)
Jan 5, 2022
Stroke, Acute Ischemic Stroke Trial in Beijing (Embotrap ?, Solitaire FR, Trevo stent retriever without inner channel)
Enrolling by invitation
- Stroke
- Acute Ischemic Stroke
- Embotrap Ⅱ
- Solitaire FR, Trevo stent retriever without inner channel
-
Beijing, ChinaXuanwu Hospital, Capital Medical University.
Jan 27, 2023
Triple Negative Breast Cancer (TNBC) Trial in China (B013+Nab-Paclitaxel)
Recruiting
- Triple Negative Breast Cancer (TNBC)
-
Guangzhou, Guangdong, China
- +6 more
Jan 29, 2023
Healthy Trial in Madrid (Oral Nutritional Supplement, Glucose)
Completed
- Healthy
- Oral Nutritional Supplement
- Glucose
-
Madrid, SpainInstitute for Health Research IdiPAZ
Apr 18, 2022
Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in Worldwide (VS-6766, VS-6766 and Defactinib)
Recruiting
- Non Small Cell Lung Cancer
- KRAS Activating Mutation
- avutometinib (VS-6766)
- avutometinib (VS-6766) and Defactinib
-
Duarte, California
- +44 more
Dec 22, 2022